SCHEMBL15427128

SCHEMBL15427128

CCCCOc1cccc2c1C(=O)c1c(OCCCC)cc(C(=O)N=[N+]=[N-])cc1C2=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 8/20 0.50
TTR P02766 3/20 0.45
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
ABCC4 O15439 1/20 0.44
USP2 O75604 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
HSP90AA1 P07900 1/20 0.44
CHRM2 P08172 1/20 0.44
HSP90AB1 P08238 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA2A P08913 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
MAPT P10636 1/20 0.44
CHRM1 P11229 1/20 0.44
PKM P14618 1/20 0.44
HPGD P15428 1/20 0.44
SLC6A2 P23975 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15427133 0.95 TTR (0.46) ELANETTRKDM4EMEN1ABCC4
SCHEMBL15427184 0.90 TTR (0.56) ELANETTRKDM4EMEN1ABCC4
SCHEMBL15427185 0.88 TTR (0.42) ELANETTRKDM4EMEN1ABCC4
SCHEMBL15427084 0.88 TTR (0.43) ELANETTRKDM4EMEN1ABCC4
SCHEMBL30760693 0.87 SLC37A4 (0.43) ELANETTRKDM4EMEN1ABCC4
SCHEMBL30760694 0.86 SLC37A4 (0.48) ELANETTRKDM4EMEN1ABCC4
SCHEMBL15427164 0.85 TTR (0.45) ELANETTRKDM4EMEN1ABCC4
SCHEMBL9169332 0.83 TTR (0.62) ELANETTRKDM4EMEN1ABCC4
SCHEMBL15427167 0.83 TTR (0.42) ELANETTRKDM4EMEN1ABCC4
SCHEMBL16919800 0.83 TTR (0.44) TTRKDM4EMEN1ABCC4USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2015-07-23 US disclosed
WO-2014011753-A2 ANTHRAQUINONE ANALOGS AND METHODS OF MAKING AND USING THEREOF GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2014-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof PCNA, KRAS, RECQL ELANE 815/4885TTR 4284/4885KDM4E 1197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.